Brain Research Center Zwolle

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease4 trials
• Depression1 trial
• Lewy body dementia1 trial
• Mild cognitive impairment1 trial
• Parkinson disease1 trial

Phase

• Phase 25 trials
• Phase 11 trial
• Phase 31 trial

Status

• Completed6 trials
• Not yet recruiting1 trial

Lead sponsor

• Alzheon Inc.1 trial
• Cognition Therapeutics1 trial
• EIP Pharma Inc1 trial
• Eli Lilly and Company1 trial
• Hoffmann-La Roche1 trial
• and 2 more

Running trials

• Not yet recruiting

  A Study of Brenipatide in Participants With Major Depressive Disorder

  NCT07928245· Phase 2· Eli Lilly and Company· Source

  Contact: Roel Mocking (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression1 recruiting

Closed trials

• Completed

  RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

  NCT05869669· Phase 2· EIP Pharma Inc· Source

• Completed

  ASURE: Alzheimer Study Using oRal Edaravone

  NCT05323812· Phase 2· Treeway B.V.· Source

• Completed

  A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

  NCT05924243· Phase 1· Hoffmann-La Roche· Source

• Completed

  An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

  NCT04770220· Phase 3· Alzheon Inc.· Source

• Completed

  A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD

  NCT04498650· Phase 2· Vivoryon Therapeutics N.V.· Source

• Completed

  A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

  NCT03507790· Phase 2· Cognition Therapeutics· Source